華盛昌(002980.SZ)一季度淨利潤預降49.77%-60.93%
格隆匯 4 月 14日丨華盛昌(002980.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤3500萬元-4500萬元,同比下降49.77%-60.93%;扣除非經常性損益後的淨利潤3000萬元-4000萬元,同比下降53.59%-65.19%。
報吿期內,隨着國內外新型冠狀病毒肺炎疫情進一步受控,非接觸紅外人體測温儀產品和紅外熱像儀產品銷售大幅下降,導致公司整體業績同比出現較大下降。雖然公司整體業績出現下降,但扣除非接觸紅外人體測温儀產品和紅外熱像儀產品的影響,公司其他產品銷售收入同比實現了增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.